| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 6.25T | 5.52T | 5.26T | 5.00T | 4.48T |
| Gross Profit | 2.00T | 1.69T | 1.55T | 1.41T | 1.26T |
| EBITDA | 779.32B | 673.09B | 450.87B | 476.19B | 458.86B |
| Net Income | 432.29B | 324.08B | 284.95B | 213.91B | 203.48B |
Balance Sheet | |||||
| Total Assets | 7.39T | 6.38T | 6.17T | 5.58T | 5.11T |
| Cash, Cash Equivalents and Short-Term Investments | 734.78B | 823.04B | 817.78B | 706.82B | 789.31B |
| Total Debt | 364.85B | 360.66B | 394.64B | 400.76B | 329.46B |
| Total Liabilities | 2.74T | 2.30T | 2.30T | 2.22T | 2.01T |
| Stockholders Equity | 4.50T | 3.95T | 3.74T | 3.24T | 2.98T |
Cash Flow | |||||
| Free Cash Flow | 402.74B | 229.83B | 206.47B | -8.85B | 126.31B |
| Operating Cash Flow | 610.73B | 455.90B | 415.48B | 166.71B | 282.37B |
| Investing Cash Flow | -365.28B | -191.75B | -94.12B | -148.53B | -114.87B |
| Financing Cash Flow | -323.10B | -265.33B | -240.12B | -119.57B | -241.32B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | $130.49B | 61.49 | 42.06% | 0.11% | 28.95% | 130.56% | |
78 Outperform | $8.27B | 15.10 | 16.61% | 0.67% | 5.20% | -0.12% | |
78 Outperform | $25.99B | 33.98 | 13.36% | 0.84% | 34.18% | -15.12% | |
77 Outperform | $83.91B | 24.37 | 9.80% | 1.05% | 7.71% | 28.29% | |
74 Outperform | $8.57B | 23.86 | 15.71% | 0.18% | 15.89% | 3.60% | |
71 Outperform | $24.88B | 35.87 | 24.45% | 1.18% | 7.18% | 14.32% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |